Medpace Holdings, Inc. (MEDP) — Analyst outlook / Analyst consensus target is. Based on 17 analyst ratings, the consensus is bullish — 4 Buy, 12 Hold, 1 Sell.
The consensus price target is $534.17 (low: $460.00, high: $582.00), representing an upside of 2.7% from the current price $520.00.
Analysts estimate Earnings Per Share (EPS) of $11.94 and revenue of $2.11B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $13.06 vs est $11.94 (beat +9.4%). 2025: actual $15.64 vs est $14.80 (beat +5.6%). Analyst accuracy: 93%.
MEDP Stock — 12-Month Price Forecast
$534.17
▲ +2.72% Upside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for Medpace Holdings, Inc., the average price target is $534.17, with a high forecast of $582.00, and a low forecast of $460.00.
The average price target represents a +2.72% change from the last price of $520.00.
Highest Price Target
$582.00
Average Price Target
$534.17
Lowest Price Target
$460.00
MEDP Analyst Ratings
Hold
Based on 17 analysts giving stock ratings to Medpace Holdings, Inc. in the past 3 months
EPS Estimates — MEDP
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $13.06
vs Est $11.94
▲ 8.6% off
2025
Actual $15.64
vs Est $14.80
▲ 5.3% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — MEDP
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.109B
vs Est $2.106B
▲ 0.1% off
2025
Actual $2.530B
vs Est $2.511B
▲ 0.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
